Top compounds associated with response to RP11-286N22.8


Feature Type Standardized
Nominal ANOVA
mRNA simvastatin CTRPv2 pan-cancer AAC 0.021 0.6
mRNA EX-527 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA KH-CB19 CTRPv2 pan-cancer AAC -0.024 0.6
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA phloretin CTRPv2 pan-cancer AAC 0.018 0.6
mRNA barasertib CTRPv2 pan-cancer AAC 0.017 0.6
mRNA regorafenib CTRPv2 pan-cancer AAC 0.019 0.6
mRNA BEC CTRPv2 pan-cancer AAC -0.039 0.6
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.019 0.6
Download CSV